This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit February 12, 2015
Advertisement
   NAMCP Medical Directors Institute   AAMCN    AAIHDS    Conferences    JMCM    Contact Us  

Check out JMCM’s new website at www.jmcmpub.org

We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!

We wanted you to be aware that FDA-approved Hysingla™ ER (hydrocodone bitartrate) extended-release tablets CII has commercially launched in the U.S. Please click here to view the press release.

Click here for a CME/CEU activity on Improving Treatment of Atrial Fibrillation and Stoke

Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.

Click here to view our Complimentary Online CME/CEU Webcasts

 

Register today: 2015 Spring Managed Care Forum

Register today for the 2015 Spring Forum being held April 23-24, 2015 at Disney's Yacht & Beach Club. Click here to visit the conference website.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




GENOMICS


23andMe finds genes for motion sickness
TIME
The personal genomics company 23andMe has identified 35 genetic factors tied to motion sickness, according to a new study published in the journal Human Molecular Genetics. In what the company says is the first ever genome-wide study looking at motion sickness, 23andMe was able to determine several genes that may be tied to the nausea associated with movement in a car or on a boat.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Light-activated genes might be precisely controlled and targeted
Phys.org
Duke University researchers have devised a method to activate genes in any specific location or pattern in a lab dish with the flip of a light switch by crossing a bacterium's viral defense system with a flower's response to sunlight.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Gene changes make humans' sense of taste unique
Smithsonian
Our relationship with food is part of being human. Meals are time for ritual and a chance to strengthen social bonds over the work of cooking and eating. But what and how we eat also helped make us human, to begin with: Changes in our eating habits also shaped our genes.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Personalized medicine is promising but needs smarter regulation
Forbes
In a high-profile White House event attended by medical researchers, patients’ advocates and drug and biotechnology company executives on Jan. 30, President Barack Obama plugged medicine’s new mantra, “the right dose of the right drug for the right patient at the right time.”
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Measure, Monitor Immunoglobulin Treatment Outcomes
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.

Request more information or schedule a personal introduction.
 


The problem with precision medicine
The New Yorker
Recently, in a speech at the White House, President Barack Obama unveiled what he called his Precision Medicine Initiative, a $215 million plan to collect genetic information from a million American volunteers in order to further the development of personalized, genetics-based medical treatments. Obama called precision medicine “one of the greatest opportunities for new medical breakthroughs that we have ever seen,” saying that it promised to deliver “the right treatments at the right time, every time, to the right person.”
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Medicine just for you
The New York Times
President Barack Obama’s new budget contains a farsighted proposal that could ultimately transform the practice of American medicine. The proposal seeks to design treatments for the individual, which are sometimes called “personalized medicine” or “precision medicine” to distinguish them from the one-size-tries-to-fit-all approach.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Stem cells can repair brain damage from radiation therapy
Radiation Therapy News
Researchers at the Memorial Sloan Kettering Cancer Center recently reported that it was possible to repair brain damage caused by radiation therapy for brain cancer by using lab-generated cells derived from human stem cells. The study was published in the journal Cell Stem Cell, and entitled “Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation.”
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Creative Medical seeks patent for stem cell therapy for MS
Multiple Sclerosis News Today
Phoenix-based Creative Medical Health has just announced it has submitted a patent application for its proprietary mesenchymal stem cell pipeline product, indicated for autoimmune diseases. The company is already preparing to launch the product into its first line of clinical tests, which will focus first on multiple sclerosis.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


EMERGING MEDICAL TECHNOLOGIES


Vendors lagging with patient engagement technology
Healthcare IT News
Despite conditions across the healthcare industry that should be driving big changes in between-visit and post-discharge communications, most providers are still doing the "bare minimum" with regard to patient engagement, according to a new report from Chilmark Research. Advances in mobile and cloud technologies, consumerization of care delivery, meaningful use incentive payments and a broader move toward value-based reimbursement would seem to be creating ripe conditions for more fruitful engagement initiatives.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


How integrating technologies can change the way healthcare is delivered
Forbes
What do Google’s driverless car, a cab service company and an online medical care scheduling service have in common? Nothing really, but in the perfect world, they’d be working together to deliver the perfect healthcare solution in our society. Skeptical? Technology has already started to transformed the healthcare industry.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACCOUNTABLE CARE ORGANIZATIONS


Groups weigh in on health IT provisions of CMS' ACO program
iHealthBeat
Healthcare organizations are urging CMS to provide more real-time data to accountable care organizations participating in the Medicare Shared Savings Program, Health Data Management reports. The letters came in response to a proposed rule released by CMS in December 2014 that includes provisions designed to increase health IT use among MSSP participants.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Accountable care takes new forms as fee-for-service fades
Health IT Analytics
Accountable care agreements are proliferating in shape and structure as healthcare providers begin to leave behind fee-for-service reimbursement in earnest. While hundreds of new organizations are engaging in the standard risk-sharing arrangement every year, some are taking collaborative care and population health management to new heights with innovative structures to improve care quality and reduce costs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


FDA clears 1st neck-access neuroprotection for carotid stenting
Medscape
The U.S. Food and Drug Administration has cleared the Enroute Transcarotid Neuroprotection System to reduce the risk for stroke during carotid angioplasty and stenting, the first such device to use neck rather than groin access.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Anticoagulant Savaysa now available for prescribing
MPR
Daiichi Sankyo announced that Savaysa tablets are now available to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep vein thrombosis and pulmonary embolism following 5–10 days of initial therapy with a parenteral anticoagulant.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MANAGED HEALTHCARE NEWS


CMS plans to shorten meaningful use Stage 2 to 90 days
By Scott Rupp
The Centers for Medicare & Medicaid Services buckled, or so it seems. After much conjecture, gesturing and soapbox shouting from healthcare leaders, it looks like the reporting period for sending data collected in the electronic health record as part of meaningful use Stage 2 will be shortened from 365 days to 90. According to SearchHealthIT, "The time and money required to attest for a 365-day reporting period gave heartburn to many hospitals and physicians."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


You have a week left to get health insurance this year
TIME
The Obamacare deadline to sign up for a policy is Feb. 15. Here's what you need to do to make sure you're covered. Time is running out. The open enrollment period for buying individual health insurance for 2015 ends Feb. 15. Miss this important deadline, and you could remain uninsured all year — and face a steep tax penalty.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Feb. 5, 2015
Jan. 29, 2015
Jan. 22, 2015
Jan. 15, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063